Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

COLMASIS

Class 5Status: Registered
Application Number4040332
Trademark Status
Registered
Trademark Class5
Application Date2018-12-28
Proprietor NameROCKMED PHARMA PRIVATE LIMITED
Appropriate OfficeDELHI
StateDELHI
Trademark TypeWORD
User DetailsProposed to be used
Agent NameMACE CORPORATE ASSOCIATES[1779]
Agent Address208A/6A, IST FLOOR SAVITRI NAGAR MALVIYA NAGAR NEW DELHI-17
Goods And Services Details[CLASS : 5] PHARMACEUTICAL AND MEDICINAL PREPARATIONS AND DIETETIC SUBSTANCES FOR MEDICAL USE

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
COLMASIS5Registered
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about COLMASIS.

What is the status of trademark application 4040332?
The current status of trademark application 4040332 for COLMASIS is Registered.
What is the trademark class of COLMASIS?
COLMASIS is registered under trademark class 5.
Who is the proprietor of COLMASIS?
The proprietor of COLMASIS is ROCKMED PHARMA PRIVATE LIMITED.
When was trademark application 4040332 filed?
Trademark application 4040332 for COLMASIS was filed on 2018-12-28.